tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF

Paradigm Biopharmaceuticals Ltd. (PBIGF) Income Statement

10 Followers

Paradigm Biopharmaceuticals Ltd. Income Statement

Last quarter (Q4 2022), Paradigm Biopharmaceuticals Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Paradigm Biopharmaceuticals Ltd.'s net income was AU$―. See Paradigm Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 79.22KAU$ 20.55K---
Cost of Revenue
-AU$ 143.75KAU$ 99.14K---
Gross Profit
-AU$ -64.53KAU$ -78.59K---
Operating Expense
-AU$ 47.93MAU$ 43.31MAU$ 17.04MAU$ 10.22MAU$ 8.93M
Operating Income
-AU$ -47.99MAU$ -43.39MAU$ -17.04MAU$ -10.22MAU$ -8.93M
Net Non Operating Interest Income Expense
-AU$ 23.11KAU$ 171.40KAU$ 963.48KAU$ 261.71KAU$ 53.90K
Other Income Expense
-AU$ 8.66MAU$ 8.71MAU$ 3.70MAU$ -5.67MAU$ 2.68M
Pretax Income
-AU$ -39.25MAU$ -34.30MAU$ -12.30MAU$ -15.63MAU$ -6.19M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -39.25MAU$ -34.30MAU$ -12.30MAU$ -15.63MAU$ -6.19M
Basic EPS
-AU$ -0.17AU$ -0.17AU$ -0.06AU$ -0.11AU$ -0.05
Diluted EPS
-AU$ -0.17AU$ -0.17AU$ -0.06AU$ -0.11AU$ -0.05
Basic Average Shares
-AU$ 234.37MAU$ 204.90MAU$ 201.11MAU$ 143.04MAU$ 116.17M
Diluted Average Shares
-AU$ 234.37MAU$ 204.90MAU$ 201.11MAU$ 143.04MAU$ 116.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -39.25MAU$ -34.30MAU$ -12.30MAU$ -15.63MAU$ -6.19M
Normalized Income
-AU$ -39.25MAU$ -34.30MAU$ -12.30MAU$ -8.70MAU$ -6.19M
Interest Expense
-AU$ 28.63KAU$ 37.72KAU$ 34.17K--
EBIT
-AU$ -39.22MAU$ -34.26MAU$ -12.26MAU$ -10.22MAU$ -8.93M
EBITDA
-AU$ -39.16MAU$ -34.05MAU$ -12.19MAU$ -10.22MAU$ -8.93M
Currency in AUD

Paradigm Biopharmaceuticals Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis